Carly E. Siskind

2.7k total citations
33 papers, 1.3k citations indexed

About

Carly E. Siskind is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Carly E. Siskind has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 14 papers in Neurology and 10 papers in Molecular Biology. Recurrent topics in Carly E. Siskind's work include Hereditary Neurological Disorders (22 papers), Genetic Neurodegenerative Diseases (18 papers) and Botulinum Toxin and Related Neurological Disorders (10 papers). Carly E. Siskind is often cited by papers focused on Hereditary Neurological Disorders (22 papers), Genetic Neurodegenerative Diseases (18 papers) and Botulinum Toxin and Related Neurological Disorders (10 papers). Carly E. Siskind collaborates with scholars based in United States, United Kingdom and Australia. Carly E. Siskind's co-authors include Michael E. Shy, Shawna Feely, Lindsey J. Miller, A. Saporta, Mary M. Reilly, John Day, Matilde Laurá, Richard A. Lewis, Mary B. Davis and Steven S. Scherer and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Carly E. Siskind

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Carly E. Siskind

Since Specialization

Citations

This map shows the geographic impact of Carly E. Siskind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carly E. Siskind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carly E. Siskind more than expected).

Fields of papers citing papers by Carly E. Siskind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carly E. Siskind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carly E. Siskind. The network helps show where Carly E. Siskind may publish in the future.

Co-authorship network of co-authors of Carly E. Siskind

This figure shows the co-authorship network connecting the top 25 collaborators of Carly E. Siskind. A scholar is included among the top collaborators of Carly E. Siskind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carly E. Siskind. Carly E. Siskind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years 2023 ·Journal of the Peripheral Nervous System ·Tong Wu, Richard S. Finkel, Carly E. Siskind, Shawna Feely, Joshua Burns, Mary M. Reilly, Francesco Muntoni, Evelin Milev, (unknown), Michael E. Shy, Sindhu Ramchandren	4
2	Validation of the parent‐proxy pediatric Charcot‐Marie‐Tooth disease quality of life outcome measure 2023 ·Journal of the Peripheral Nervous System ·Tong Wu, Richard S. Finkel, Carly E. Siskind, Shawna Feely, Joshua Burns, Mary M. Reilly, Francesco Muntoni, (unknown), Michael E. Shy, Sindhu Ramchandren	4
3	Supervision in genetic counselor training in North America: A systematic review 2019 ·Journal of Genetic Counseling ·Carly E. Siskind, Carrie Atzinger	3
4	Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington’s Disease Community 2019 ·Journal of Huntington s Disease ·Kristina Cotter, Carly E. Siskind, Sharon J. Sha, Andrea Hanson‐Kahn	12
5	Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy 2018 ·Journal of Neuromuscular Diseases ·(unknown), Carly E. Siskind, John Day, Holly K. Tabor	32
6	“This could be me”: exploring the impact of genetic risk for Huntington’s disease young caregivers 2018 ·Journal of Community Genetics ·(unknown), Andrea Hanson‐Kahn, Melinda S. Kavanaugh, Carly E. Siskind, Joanna H. Fanos	12
7	Charcot Marie Tooth disease type 4J with complex central nervous system features 2018 ·Annals of Clinical and Translational Neurology ·James P. Orengo, Pravin Khemani, John Day, Jun Li, Carly E. Siskind	16
8	Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy 2014 ·Neuromuscular Disorders ·Julien Couthouis, Alya R. Raphael, Carly E. Siskind, Andrew R. Findlay, Jason D. Buenrostro, William J. Greenleaf, Hannes Vogel, John Day, Kevin M. Flanigan, Aaron D. Gitler	28
9	Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·Sindhu Ramchandren, Michael E. Shy, Eva L. Feldman, Ruth C. Carlos, Carly E. Siskind	6
10	Muscular Dystrophy Association U.S. Neuromuscular Disease Registry - Preliminary Findings (P7.008) 2014 ·Neurology ·(unknown), Joline Dalton, Valerie Cwik, Annie Kennedy, (unknown), Jane Larkindale, Alan H. Beggs, Joshua O. Benditt, James D. Berry, Thomas O. Crawford, (unknown), Rachel Richesson, Jeffrey Rosenfeld, Carly E. Siskind, Kevin M. Flanigan	1
11	Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations 2014 ·Brain Research ·Alya R. Raphael, Julien Couthouis, Sarada Sakamuri, Carly E. Siskind, Hannes Vogel, John Day, Aaron D. Gitler	29
12	X inactivation in females with X-linked Charcot–Marie–Tooth disease 2012 ·Neuromuscular Disorders ·Sinéad M. Murphy, (unknown), James M. Polke, Carly E. Siskind, Matilde Laurá, (unknown), Gita Ramdharry, Henry Houlden, Raymond P. Murphy, Michael E. Shy, Mary M. Reilly	20
13	MFN2 mutations cause severe phenotypes in most patients with CMT2A 2011 ·Neurology ·Shawna Feely, Matilde Laurá, Carly E. Siskind, (unknown), Mary B. Davis, (unknown), Mary M. Reilly, Michael E. Shy	154
14	Genetics of Neuropathies 2011 ·Seminars in Neurology ·Carly E. Siskind, Michael E. Shy	12
15	Charcot‐marie‐tooth disease subtypes and genetic testing strategies 2011 ·Annals of Neurology ·A. Saporta, (unknown), Lindsey J. Miller, Shawna Feely, Carly E. Siskind, Michael E. Shy	383
16	Phenotype expression in women with CMT1X 2011 ·Journal of the Peripheral Nervous System ·Carly E. Siskind, Sinéad M. Murphy, (unknown), James M. Polke, Mary M. Reilly, Michael E. Shy	37
17	Exome sequencing allows for rapid gene identification in a Charcot‐Marie‐Tooth family 2011 ·Annals of Neurology ·(unknown), Eric Powell, Jiaqiang Huang, Fiorella Speziani, Yvonne J. K. Edwards, Gary W. Beecham, William Hulme, Carly E. Siskind, Jeffery M. Vance, Michael E. Shy, Stephan Züchner	83
18	Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease 2010 ·Journal of the Neurological Sciences ·Allon Goldberg, Stacey L. Schepens Niemiec, Shawna Feely, James Garbern, Lindsey J. Miller, Carly E. Siskind, (unknown)	16
19	Persistent CNS dysfunction in a boy with CMT1X 2009 ·Journal of the Neurological Sciences ·Carly E. Siskind, Shawna Feely, Saunder Bernes, Michael E. Shy, James Garbern	31
20	PMP22 expression in dermal nerve myelin from patients with CMT1A 2009 ·Brain ·István Katona, (unknown), Shawna Feely, (unknown), Carly E. Siskind, Laurence Miller, Michael E. Shy, Jun Li	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact